- Feb 5, 2002
- 182,436
- 66,034
- Country
- United States
- Gender
- Female
- Faith
- Catholic
- Marital Status
- Married
- Politics
- US-Others
The U.S. Federal Trade Commission is investigating potential “unfair or deceptive trade practices” regarding transgender surgeries and drugs.
The launch of the federal inquiry is designed to “gauge the harms consumers may be experiencing” from “false or unsupported claims” about transgender treatment, according to a press release. The inquiry focuses on affected minors but is also open to adults who have been affected.
The agency’s investigation comes after President Donald Trump pledged to end federal support for transition drugs and surgeries in an executive order he issued at the outset of his administration this year.
The Federal Trade Commission, a federal agency that promotes marketplace competition and consumer education, will investigate whether practitioners have violated a long-standing law against deception in the marketplace.
Continued below.
www.catholicnewsagency.com
The launch of the federal inquiry is designed to “gauge the harms consumers may be experiencing” from “false or unsupported claims” about transgender treatment, according to a press release. The inquiry focuses on affected minors but is also open to adults who have been affected.
The agency’s investigation comes after President Donald Trump pledged to end federal support for transition drugs and surgeries in an executive order he issued at the outset of his administration this year.
The Federal Trade Commission, a federal agency that promotes marketplace competition and consumer education, will investigate whether practitioners have violated a long-standing law against deception in the marketplace.
Continued below.
Federal Trade Commission launches inquiry into harm of ‘gender-affirming care’
The U.S. Federal Trade Commission is investigating potential “unfair or deceptive trade practices” regarding transgender surgeries and drugs.
www.catholicnewsagency.com
